Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07691476
What this trial is testing

Multicenter Single-Arm Clinical Trial of Zanzalintinib and Pembrolizumab in Subjects With Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Patients With Locally Advanced or Metastatic But Resectable Clear Cell Renal Cell Carcinoma
Yonsei University 48
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)Ended earlyNCT02782715
What this trial is testing

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
University of Wisconsin, Madison 3
Testing effectiveness (Phase 2)Ended earlyNCT00323076
What this trial is testing

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Who this might be right for
Renal Cell CarcinomaNeuroendocrine Tumours
AHS Cancer Control Alberta 92
Not applicableEnded earlyNCT00942058
What this trial is testing

Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Kidney CancerMetastatic Renal Cell Carcinoma
Centre Hospitalier Universitaire de Saint Etienne 16
Testing effectiveness (Phase 2)Study completedNCT01176552
What this trial is testing

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 35
Large-scale testing (Phase 3)UnknownNCT00047138
What this trial is testing

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

Who this might be right for
Kidney Cancer
University of Leicester 350
Testing effectiveness (Phase 2)Ended earlyNCT00853125
What this trial is testing

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)UnknownNCT05172440
What this trial is testing

A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC

Who this might be right for
Neoadjuvant Therapy
Hongqian Guo 20
Testing effectiveness (Phase 2)Ended earlyNCT00318110
What this trial is testing

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research 4
Not applicableStudy completedNCT03900364
What this trial is testing

A Prospective Trial Comparing Robot-assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy

Who this might be right for
Carcinoma, Renal CellRenal Malignant TumorRenal Cyst+1 more
Salzburger Landeskliniken 30
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00059813
What this trial is testing

Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Testing effectiveness (Phase 2)UnknownNCT02828709
What this trial is testing

Safety and Feasibility of IRE for SRMs

Who this might be right for
Kidney Cancer
Dr. Prof. M.P. Laguna Pes 20
Next Page